The femtomolar-acting NAP interacts with microtubules: Novel aspects of astrocyte protection

Journal of Alzheimer's Disease

Volumn 6, Issue SUPPL., 2004, Pages

  Gozes, Illana ^a   Divinski, Inna ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; ASPARAGINYLALANYLPROLYLVALYLSERYLISOLEUCYLPROLYLGLUTAMINE; GLUTAMINE DERIVATIVE; OCTAPEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL DIVISION; CELL PROTECTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; GLIA CELL; IMMUNOREACTIVITY; IN VITRO STUDY; INCUBATION TIME; INTOXICATION; MICROTUBULE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; RAT;

EID: 13444287985     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2004-6s605     Document Type: Article

References (33)

1. A.D.C. Alonso, T. Zaidi, M. Noivak, I. Grundke-Iqbal and K. Iqbal, Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments, Proc. Natl. Acad. Sci. USA 98 (2001), 6923-6928.
2. A. Alvarez-Buylla and D.A. Lim, For the long run: maintaining germinal niches in the adult brain, Neuron 41 (2004), 683-686.
3. S. Aronov, R. Marx and I. Ginzburg, Identification of 3'UTR region implicated in tau mRNA stabilization in neuronal cells, J. Mol. Neurosci. 12 (1999), 131-145.
4. O. Ashur-Fabian, Y. Segal-Ruder, E. Skutelsky, D.E. Brenneman, R. Steingart, E. Giladi and I. Gozes, The neuroprotective peptide NAP inhibits the aggregation of the beta-amyloid peptide, Peptides 24 (2003), 1413-1423.
5. M. Bassan, R. Zamostiano, A. Davidson, A. Pinhasov, E. Giladi, O. Perl, H. Bassan, C. Blat, G. Gibney, G. Glazner, D.E. Brenneman and I. Gozes, Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochem 72 (1999), 1283-1293.
6. D.E. Brenneman and I. Gozes, A femtomolar-acting neuroprotective peptide, J. Clin. Invest. 97 (1996), 2299-2307.
7. D.E. Brenneman, J. Hauser, E. Neale, S. Rubinraut, M. Fridkin, A. Davidson and I. Gozes, Activity-dependent neurotrophic factor: structure-activity relationships of femtomolar-acting peptides, J. Pharmacol. Exp. Therap. 285 (1998), 619-627.
8. D.E. Brenneman, C.Y. Spong, H.M. Hauser, D. Abebe, A. Pinhasov, T. Golian and I. Gozes, Protective Peptides that are Orally Active and Mechanistically Non-chiral, J. Pharmacol. Exp. Ther. 309 (2004), 1190-1197.
9. D.W. Cleveland, S.Y. Hwo and M.W. Kirschner, Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin, J. Mol. Biol. 116 (1977), 207-225.
10. I. Divinski, L. Mittelman and I. Gozes, A femtomolar-acting octapeptide interacts with tubulin and protects astrocytes against zinc intoxication, J Biol. Chem. 279 (2004), 28531-28538.
11. M.L. Garcia and D.W. Cleveland, Going new places using an old MAP: tau, microtubules and human neurodegenerative disease, Curr. Opin. Cell. Biol. 13 (2001), 41-48.
12. I. Gozes and U.Z. Littauer, Tubulin microheterogeneity increases with rat brain maturation, Nature 276 (1978), 411-413.
13. I. Gozes and K.J. Sweadner, Multiple forms of tubulinare expressed by a single neuron, Nature 294 (1981), 477-480.
14. I. Gozes and C.J. Barnstable, Monoclonal antibodies that recognize discrete forms of tubulin, Proc. Natl. Acad. Sci. USA 79 (1982), 2579-2583.
15. I. Gozes and D.E. Brenneman, A new concept in the pharmacology of neuroprotection, J. Molec. Neurosci. 14 (2000), 61-68.
16. I. Gozes, Neuroprotective peptide drug delivery and development: potential new therapeutics, Trends Neurosci 24 (2001), 700-705.
17. I. Gozes, Tau as a drug target in Alzheimer's disease, J Mol Neurosci 19 (2002), 337-338.
18. I. Gozes, I. Divinsky, I. Pilzer, M. Fridkin, D.E. Brenneman and A.D. Spier, From vasoactive intestinal peptide (VIP) through activity-dependent neuroprotective protein (ADNP) to NAP: a view of neuroprotection and cell division, J. Mol. Neurosci. 20 (2003), 315-322.
19. M. Higuchi, V.M. Lee and J.Q. Trojanowski, Tau and axonopathy in neurodegenerative disorders, Neuromolecular Med 2 (2002), 131-150.
20. K. Iqbal, H.M. Wisniewski, M.L. Shelanski, S. Brostoff, B.H. Liwnicz and R.D. Terry, Protein changes in senile dementia, Brain Res 77 (1974), 337-343.
21. M.L. Michaelis, R.T. Dobrowsky and G. Li, Tau neurofibrillary pathology and microtubule stability, J Mol Neurosci 19 (2002), 289-293.
22. J. Nunez and I. Fischer, Microtubule-associated proteins (MAPs) in the peripheral nervous system during development and regeneration, J. Mol. Neurosci. 8 (1997), 207-222.
23. A. Pinhasov, S. Mandel, A. Torchinsky, E. Giladi, Z. Pittel, A.M. Goldweig, S.J. Servoss, D.E. Brenneman and I. Gozes, Activity-dependent neuroprotective peptide: a novel gene essential for brain formation, Dev. Brain. Res. 144 (2003), 83-90.
24. E. Plassart-Schiess and E.E. Baulieu, Neurosteroids: recent findings, Brain Res. Brain Res. Rev. 37 (2001), 133-140.
25. P. Petrova, A. Raibekas, J. Pevsner, N. Vigo, M. Anafi, M.K. Moore, A.E. Peaire, V. Shridhar, D.I. Smith, J. Kelly, Y. Durocher and J.W. Commissiong, MANF: a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity for dopaminergic neurons, J Mol Neurosci 20 (2003), 173-188.
26. N. Sanai, A.D. Tramontin, A. Quinones-Hinojosa, N.M. Barbaro, N. Gupta, S. Kunwar, M.T. Lawton, M.W. McDermott, A.T. Parsa, J. Manuel-Garcia Verdugo, M.S. Berger and A. Alvarez-Buylla, Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration, Nature 427 (2004), 740-744.
27. R.A. Santarella, G. Skiniotis, K.N. Goldie, P. Tittmann, H. Gross, E.M. Mandelkow, E. Mandelkow and A. Hoenger, Surface-decoration of Microtubules by Human Tau, J Mol Biol 339 (2004), 539-553.
28. R.D. Terry, The cytoskeleton in Alzheimer disease, J Neural Transm Suppl 53 (1998), 141-145.
29. M.F. Wilkemeyer, S.Y. Chen, C.E. Menkari, D.E. Brenneman, K.K. Sulik and M.E. Charness, Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity, Proc. Natl. Acad. Sci. USA 100 (2003), 8543-8548.
30. Y. Yoshiyama, B. Zhang, J. Bruce, J.Q. Trojanowski and V.M. Lee, Reduction of detyrosinated microtubules and Golgi fragmentation are linked to tau-induced degeneration in astrocytes, J. Neurosci. 23 (2003), 10662-10671.
31. R. Zamostiano, A. Pinhasov, E. Gelber, R.A. Steingart, E. Seroussi, E. Giladi, M. Bassan, Y. Wollman, H.J. Eyre, J.C. Mulley, D.E. Brenneman and I. Gozes, Cloning and characterization of the human activity-dependent neuroprotective protein, J Biol Chem 276 (2001), 708-714.
32. I. Zemlyak, S. Furman, D.E. Brenneman and I. Gozes, A novel peptide prevents death in enriched neuronal cultures, Regul Pept 96 (2000), 39-43.
33. B. Zhang, M. Higuchi, Y. Yoshiyama, T. Ishihara, M.S. Forman, D. Martinez, S. Joyce, J.Q. Trojanowski and V.M. Lee, Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy, J Neurosci 24 (2004), 4657-4667.